These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38912800)

  • 1. The safety of topical vs. oral steroids in bullous pemphigoid: considerations for retrospective analyses.
    Amber KT; Feldman RJ
    Br J Dermatol; 2024 Sep; 191(4):479-480. PubMed ID: 38912800
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
    Joly P; Roujeau JC; Benichou J; Picard C; Dreno B; Delaporte E; Vaillant L; D'Incan M; Plantin P; Bedane C; Young P; Bernard P;
    N Engl J Med; 2002 Jan; 346(5):321-7. PubMed ID: 11821508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral and topical corticosteroids in bullous pemphigoid.
    Ardern-Jones MR; Venning VA; Wojnarowska F
    N Engl J Med; 2002 Jul; 347(2):143-5; author reply 143-5. PubMed ID: 12110747
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral and topical corticosteroids in bullous pemphigoid.
    Spigel GT
    N Engl J Med; 2002 Jul; 347(2):143-5; author reply 143-5. PubMed ID: 12117002
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of immune checkpoint inhibitor-induced bullous pemphigoid.
    Apalla Z; Lallas A; Delli F; Lazaridou E; Papalampou S; Apostolidou S; Gerochristou M; Rigopoulos D; Stratigos A; Nikolaou V
    J Am Acad Dermatol; 2021 Feb; 84(2):540-543. PubMed ID: 32428613
    [No Abstract]   [Full Text] [Related]  

  • 6. Tinea incognito in an old patient with bullous pemphigoid receiving topical high potency steroids.
    Liu ZH; Shen H
    J Mycol Med; 2015 Sep; 25(3):245-6. PubMed ID: 26278826
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral and topical corticosteroids in bullous pemphigoid.
    Bystryn JC; Wainwright BD; Shupack JL
    N Engl J Med; 2002 Jul; 347(2):143-5; author reply 143-5. PubMed ID: 12117001
    [No Abstract]   [Full Text] [Related]  

  • 8. Bullous pemphigoid therapy -- think globally, act locally.
    Stern RS
    N Engl J Med; 2002 Jan; 346(5):364-7. PubMed ID: 11821516
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of death, major adverse cardiac events and relapse in patients with bullous pemphigoid treated with systemic or topical corticosteroids.
    Kridin K; Bieber K; Vorobyev A; Moderegger EL; Hernandez G; Schmidt E; Ludwig RJ
    Br J Dermatol; 2024 Sep; 191(4):539-547. PubMed ID: 38798074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous pemphigoid: from bench to bedside.
    Walsh SR; Hogg D; Mydlarski PR
    Drugs; 2005; 65(7):905-26. PubMed ID: 15892587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
    Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of generalized bullous pemphigoid with oral tetracycline.
    Brakman M; Westerhof W
    J Am Acad Dermatol; 1994 Jan; 30(1):145-6. PubMed ID: 8277023
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the safety and efficacy of a potent topical cortico-steroid in the treatment of bullous pemphigoid.
    Claudy A
    Clin Dermatol; 2001; 19(6):778-80. PubMed ID: 11705688
    [No Abstract]   [Full Text] [Related]  

  • 14. Bullous pemphigoid--management of a patient with oral and skin lesions.
    Ali TB; Zain RB; Adam BA
    Singapore Dent J; 1994 Jan; 19(1):18-21. PubMed ID: 9582679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral and topical corticosteroids in bullous pemphigoid.
    Korman NJ
    N Engl J Med; 2002 Jul; 347(2):143-5; author reply 143-5. PubMed ID: 12117000
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of generalized bullous pemphigoid with oral tetracycline.
    Thomas I; Khorenian S; Arbesfeld DM
    J Am Acad Dermatol; 1993 Jan; 28(1):74-7. PubMed ID: 8425974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of bullous pemphigoid by low-dose methotrexate associated with short-term potent topical steroids: an open prospective study of 18 cases.
    Dereure O; Bessis D; Guillot B; Guilhou JJ
    Arch Dermatol; 2002 Sep; 138(9):1255-6. PubMed ID: 12225001
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid].
    Zimmermann R; Faure M; Claudy A
    Ann Dermatol Venereol; 1999 Jan; 126(1):13-6. PubMed ID: 10095883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol.
    Hornschuh B; Hamm H; Wever S; Hashimoto T; Schröder U; Bröcker EB; Zillikens D
    J Am Acad Dermatol; 1997 Jan; 36(1):101-3. PubMed ID: 8996271
    [No Abstract]   [Full Text] [Related]  

  • 20. Bullous pemphigoid following therapy with an oral beta-blocker.
    Perry A; Sparling JD; Pennington M
    J Drugs Dermatol; 2005; 4(6):746-8. PubMed ID: 16302561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.